🔍
Search Results - julian+billini
2
Results
Sort By:
Published Date
Updated Date
Title
ID
Descending
Ascending
aEYE: Automated Eye Movement Detection
Unmet Need:Eye movement frequently inform diagnoses of neurological dysfunctions and states. For example, such signatures may help gauge response to therapy, assess intoxication, and identify brain injury. A method is needed to predict and detect predict subtle eye movements for such applications. Technology Overview:Inventors at Johns Hopkins have...
Published: 3/14/2025
|
Inventor(s):
Kemar Green
,
Raimond Winslow
,
Julian Billini
,
Joseph Greenstein
,
John Morkos
,
David Newman-Toker
,
David Zee
,
Narayani Wagle
Keywords(s):
Category(s):
Technology Classifications > Computers, Electronics & Software > Algorithms
,
Technology Classifications > Computers, Electronics & Software > Artificial Intelligence
,
Technology Classifications > Computers, Electronics & Software > Machine Learning
,
Technology Classifications > Diagnostics
,
Clinical and Disease Specializations > Neurology
A p105-based NF-(kappa) B Super repressor
C04290: A p105-based NF-(kappa) B Super repressor Technical Details: Nuclear factor (NF)-kB is a family of transcription factors that regulate immune and inflammatory responses, programmed cell death (apoptosis), and developmental processes. In normal cells, NF-kB is latent, and is activated transiently by stimuli and stresses. However, under pathological...
Published: 3/13/2025
|
Inventor(s):
Li Lin
Keywords(s):
Biologics
,
Cancers
,
Chemotherapy
,
Disease Indication
,
Nucleic Acid
,
Single
,
Skin Cancer
,
Therapeutic Matter
,
Therapeutic Substance
,
Therapeutics
,
Therapy Type
Category(s):
Clinical and Disease Specializations
,
Clinical and Disease Specializations > Dermatology
,
Clinical and Disease Specializations > Oncology > Skin Cancer
,
Technology Classifications > Therapeutic Modalities > Gene Therapies
,
Technology Classifications > Therapeutic Modalities > Proteins
,
Technology Classifications > Therapeutic Modalities > Targets
,
Clinical and Disease Specializations > Oncology
,
Technology Classifications > Therapeutic Modalities
JHTV Home
|
Search
|
Login/Subscribe
2017 - 2022 © Johns Hopkins Technology Ventures. All Rights Reserved. Powered by
Inteum